Complete Clinical Recovery Following Surgical Excision of Extensive Primary Cardiac Sarcoma
Kai A Muenker1, Hannah Schoeni1, Joerg Beyer2
1Department of Cardiac Surgery, University Hospital Bern, Bern, Switzerland.
JACC. Case Reports
|December 18, 2024
Summary
Primary cardiac sarcoma is rare but treatable. Surgical debulking combined with radiotherapy offers excellent outcomes, even in extensive cases, improving patient prognosis and quality of life.
Area of Science:
- Cardiovascular Surgery
- Surgical Oncology
- Cardiac Pathology
Background:
- Primary cardiac tumors are rare, with sarcomas being the most common malignant type.
- Malignant cardiac sarcomas often require multimodal treatment including surgery, chemotherapy, and radiotherapy.
- Prognosis for cardiac sarcomas is generally poor, with median survival often under two years.
Observation:
- A 67-year-old female presented with a primary cardiac sarcoma and extensive pulmonary artery involvement.
- The patient underwent tumor debulking, pulmonary valve replacement, tricuspid valve reconstruction, and patent foramen ovale closure.
- Adjuvant radiotherapy was administered post-operatively.
Findings:
- The patient achieved remission and maintained an excellent clinical status 18 months post-treatment.
- Surgical debulking and radiotherapy combination demonstrated significant symptom relief and improved health.
- This case highlights a favorable outcome despite the typically poor prognosis of cardiac sarcomas.
Implications:
- Aggressive surgical management combined with adjuvant radiotherapy can lead to long-term remission in cardiac sarcoma.
- This approach may offer a viable therapeutic option for patients with extensive cardiac tumors, challenging conventional treatment paradigms.
- Further research into multimodal strategies for primary cardiac sarcomas is warranted to improve patient survival and quality of life.
